Molecular TherapyMolecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938.Molecular Therapy — OncolyticsMolecular Therapy—Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or transfer of cells and/or genes. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy—Oncolytics will build upon the success of Molecular Therapy and its sibling journals in publishing important peer-reviewed original research and editorial commentary.

分子治療《分子療法》雜志是基因轉移、載體開發與設計、干細胞操作、基因、肽、蛋白、寡核苷酸的開發、細胞療法、疫苗開發、臨床前目標驗證、安全性/有效性研究和臨床試驗等領域的領先期刊。分子療法致力于促進遺傳學、醫學和生物技術的科學發展。出版重要的同行評審研究和前沿評論和評論，該雜志繼續吸引該領域的最佳材料。分子治療2015年影響因子為6.938。分子療法-溶瘤療法《分子治療- oncolytics》是一本國際性的、在線的、開放獲取的雜志，專注于針對癌癥的病毒、細胞和其他生物療法的開發和臨床測試。同時提供一個獨特的論壇在新興領域的溶瘤病毒治療工作,以及T細胞,干細胞療法,《華爾街日報》將考慮所有優質,尖端研究,采用創新的分子和細胞的方法,目標腫瘤細胞破壞,是否由病毒、其他微生物,免疫接種,或轉移的細胞和/或基因。作為美國基因與細胞治療學會的官方期刊，分子治療-溶瘤學將建立在分子治療及其兄弟期刊的成功基礎上，發表重要的同行評審的原始研究和編輯評論。